Cumulus Neuroscience (Cumulus; The Company), a global digital health company focused on advancing neuroscience clinical ...
Validation data presented at the 2025 Alzheimer's & Parkinson's Diseases (AD/PD) Conference confirms two novel NeuLogiq® Platform endpoints show g ...
Validation data presented at the 2025 Alzheimer's & Parkinson's Diseases (AD/PD) Conference confirms two novel NeuLogiq® Platform endpoints show greater separation with Alzheimer's pTau217 pathology ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果